Sanofi (SNY) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.63 | 0.75 | 0.88 | 0.90 | 1.13 | 1.15 | |||
| Changes by years, y/y, % | +4% | +19% | +17% | +3% | +25% | +18.0% | |||
Sanofi. Debt/EBITDA
Sanofi. Debt/EBITDA, changes, %
Sanofi (SNY) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q3 | 2025Q2 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.36 | 1.36 | 0.74 | 1.00 | 1.15 | 1.15 | ||
| Changes by years, y/y, % | -252% | -65% | -13% | -16% | ||||
| Changes by quarters, q/q, % | +19% | +0% | -46% | +36% | +15% | |||